Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y12 Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study.
Saved in:
| Title: | Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y |
|---|---|
| Authors: | Mathew RO; Department of Medicine, Loma Linda VA Health Care System, 11201 Benton Street, Loma Linda, CA, 92357, USA. Roy.mathew@va.gov., Sidhu MS; Department of Medicine, Albany Medical College, 43 New Scotland Avenue Albany, Schenectady, NY, 12208, USA. mssidhu@yahoo.com., Rihal CS; Department of Medicine, Mayo Clinic, Rochester, MN, USA., Lennon R; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., El-Hajjar M; Department of Medicine, Albany Medical College, 43 New Scotland Avenue Albany, Schenectady, NY, 12208, USA., Yager N; Department of Medicine, Albany Medical College, 43 New Scotland Avenue Albany, Schenectady, NY, 12208, USA., Lyubarova R; Department of Medicine, Albany Medical College, 43 New Scotland Avenue Albany, Schenectady, NY, 12208, USA., Abdul-Nour K; Henry Ford Health System, Detroit, MI, USA., Weitz S; Cardiology Associates of Schenectady, Schenectady, NY, USA., O'Cochlain DF; Department of Medicine, May Clinic Health System, Eau Claire, WI, USA., Murthy V; Department of Endocrine and Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA., Levisay J; Department of Medicine, North Shore University Health System, Evanston, IL, USA., Marzo K; Department of Medicine, Winthrop University Hospital, Mineola, NY, USA., Graham J; Department of Medicine, St. Michael's Hospital, Toronto, ON, Canada., Dzavik V; Department of Medicine, University Health Network-Toronto General Hospital, Toronto, ON, Canada., So D; Department of Medicine, University of Ottawa Heart Institute, Ottawa, ON, Canada., Goodman S; Department of Medicine, St. Michael's Hospital, Toronto, ON, Canada., Rosenberg YD; National Heart Lung and Blood Institute, Bethesda, MD, USA., Pereira N; Department of Medicine, Mayo Clinic, Rochester, MN, USA., Farkouh ME; Department of Medicine, University Health Network-Toronto General Hospital, Toronto, ON, Canada. |
| Source: | Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2024 Jun; Vol. 38 (3), pp. 447-457. Date of Electronic Publication: 2022 Nov 29. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Kluwer Academic For The International Society For Cardiovascular Pharmacotherapy Country of Publication: United States NLM ID: 8712220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7241 (Electronic) Linking ISSN: 09203206 NLM ISO Abbreviation: Cardiovasc Drugs Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-7241 |
|---|---|
| DOI: | 10.1007/s10557-022-07392-2 |
